Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Multiple Sclerosis

• Publication date

  2009-08-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1352458509106612PMID 19692435
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurofibromatosis 1

  2010cited by this paper
• Neurofibromatosis 1

  2007cited by this paper
• Neurofibromatosis Types 1 and 2

  2006cited by this paper
• Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

  2005cited by this paper
• Association neurofibromatose de type I et sclérose en plaques

  2004cited by this paper
• [Multiple sclerosis associated with neurofibromatosis type I].

  2004cited by this paper
• Neurofibromatosis Type I Tumor Suppressor Neurofibromin Regulates Neuronal Differentiation via Its GTPase-activating Protein Function toward Ras*

  2003influential reference
• Neurofibromatosis type 1

  2003cited by this paper
• Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment

  2002cited by this paper
• Neurofibromatosis and glioblastoma in a case of multiple sclerosis

  2001cited by this paper
• The range of multiple sclerosis associated with neurofibromatosis type 1

  2001influential reference
• Multiple sclerosis.

  2000cited by this paper
• Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children

  2000cited by this paper
• Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.

  2000cited by this paper
• Detailed analysis of the oligodendrocyte myelin glycoprotein gene in four patients with neurofibromatosis 1 and primary progressive multiple sclerosis

  2000cited by this paper
• The OMgp gene, a second growth suppressor within the NF1 gene

  1998cited by this paper
• Neurofibromatose I et sclérose en plaques. A propos d'un cas.

  1997cited by this paper
• [Neurofibromatosis I and multiple sclerosis. Apropos of a case].

  1997cited by this paper
• [Multiple sclerosis and neurofibromatosis 1].

  1996cited by this paper
• Neurofibromatosis 1 and multiple sclerosis.

  1995cited by this paper
• Single strand conformation analysis of two genes contained within the first intron of the neurofibromatosis type I gene in patients with multiple sclerosis.

  1995cited by this paper
• Single strand conformation analysis of two genes contained within the first intron of the neurof ibromatosis type I gene in patients with multiple sclerosis

  1995cited by this paper
• MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment.

  1993cited by this paper
• Multiple sclerosis: changing times.

  1991cited by this paper
• Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

  1988cited by this paper
• National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making

  1988cited by this paper

• Neurofibromatosis type 1, sarcoidosis, and anterior uveitis: A simple coincidence or coexistence?—An interesting case report

  2025cites this paper
• Non-Optic Glioma-like Lesions in Adult Neurofibromatosis Type 1 Patients

  2024cites this paper
• Coexistence of neurofibromatosis type I, multiple sclerosis, and ischemic stroke: A case report and literature review

  2024cites this paper
• Peripheral nerve vulnerability as risk factor for multiple sclerosis: Possible insights from Neurofibromatosis type 2 (NF2).

  2022cites this paper
• Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS).

  2021cites this paper
• Primary Progressive Multiple Sclerosis in a Portuguese Patient With Neurofibromatosis Type 1

  2021cites this paper
• Multiple sclerosis in a child with neurofibromatosis type I - clinical management of a challenging case.

  2021cites this paper
• Multidisciplinary Approach to Neurofibromatosis Type 1

  2020cites this paper
• The effect of IFN‐β 1a on expression of MDA5 and RIG‐1 in multiple sclerosis patients

  2020cites this paper
• Neurofibromatosis I and multiple sclerosis

  2020cites this paper
• Neurological Complications in NF1

  2020cites this paper
• Clinical Observation of a Combination of Neurofibromatosis Type I and Multiple Sclerosis

  2020cites this paper
• Neurofibromatosis type 2 and multiple sclerosis.

  2019cites this paper
• The Effect of IFN-β 1 a on Biochemical Factors in Multiple Sclerosis Patients

  2017influential citation
• Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

  2017cites this paper
• Neurofibromatosis type 1 and multiple sclerosis: Genetically related diseases

  2017influential citation
• The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients

  2016cites this paper
• The Effect of IFN-β 1a on Biochemical Factors in Multiple Sclerosis Patients

  2016cites this paper
• Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I

  2015cites this paper
• Cooccurrence of Multiple Sclerosis and Idiopathic Basal Ganglia Calcification

  2015cites this paper
• Neurofibromatosis Type 1 and Chronic Neurological Conditions in the United States: An Administrative Claims Analysis

  2014cites this paper
• Co-existence of neurofibromatosis type 2 and multiple sclerosis: A case report.

  2014influential citation
• Neurofibromin and IL-4 as Regulators of T Cell Development, Function, and Homeostasis

  2012cites this paper
• Neuroimaging in Iran: A Review

  2010cites this paper